We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jonathan Cotliar

Jonathan Cotliar MD

Chief Medical Officer, Science 37, Faculty Physician, Harbor-UCLA Division of Dermatology, Los Angeles, California

I am a dual-trained and board-certified internist and dermatologist with a special interest in complex medical dermatology, including graft-versus-host disease, adverse drug reactions, and the management of cutaneous toxicities related to traditional chemotherapeutic agents as well as to targeted anticancer therapies.  I previously served as a full-time faculty physician at the David Geffen School of Medicine at UCLA, and at Northwestern University Feinberg School of Medicine before joining City of Hope National Medical Center to lead a new dermatology program there.  Most recently, I joined Science 37 as Vice President of Medical Affairs, a startup that employs innovative technology to expand patient access to clinical trials using a decentralized model.

Disclosures

Dr. Cotliar has not reported any disclosures.